These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 18586335

  • 1. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia.
    Premkumar P, Fannon D, Kuipers E, Cooke MA, Simmons A, Kumari V.
    Behav Brain Res; 2008 Nov 03; 193(1):132-9. PubMed ID: 18586335
    [Abstract] [Full Text] [Related]

  • 2. Lower prefrontal gray matter volume in schizophrenia in chronic but not in first episode schizophrenia patients.
    Molina V, Sanz J, Sarramea F, Benito C, Palomo T.
    Psychiatry Res; 2004 May 30; 131(1):45-56. PubMed ID: 15246454
    [Abstract] [Full Text] [Related]

  • 3. Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study.
    Wilke M, Kaufmann C, Grabner A, Pütz B, Wetter TC, Auer DP.
    Neuroimage; 2001 May 30; 13(5):814-24. PubMed ID: 11304078
    [Abstract] [Full Text] [Related]

  • 4. Frontal lobe volumes in schizophrenia: effects of stage and duration of illness.
    Premkumar P, Kumari V, Corr PJ, Sharma T.
    J Psychiatr Res; 2006 Oct 30; 40(7):627-37. PubMed ID: 16901506
    [Abstract] [Full Text] [Related]

  • 5. A longer duration of schizophrenic illness has sex-specific associations within the working memory neural network in schizophrenia.
    Elsabagh S, Premkumar P, Anilkumar AP, Kumari V.
    Behav Brain Res; 2009 Jul 19; 201(1):41-7. PubMed ID: 19428614
    [Abstract] [Full Text] [Related]

  • 6. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
    Suzuki M, Zhou SY, Takahashi T, Hagino H, Kawasaki Y, Niu L, Matsui M, Seto H, Kurachi M.
    Brain; 2005 Sep 19; 128(Pt 9):2109-22. PubMed ID: 15930048
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK, Phillips I, Jazayerli R, Barnett A, Coppola R, Weinberger DR.
    Psychiatry Res; 2006 Dec 01; 148(2-3):121-32. PubMed ID: 17097276
    [Abstract] [Full Text] [Related]

  • 9. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M, Bédard MA, Stip E.
    Encephale; 2001 Dec 01; 27(5):405-15. PubMed ID: 11760690
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Grey matter deficits and symptom profile in first episode schizophrenia.
    Whitford TJ, Farrow TF, Gomes L, Brennan J, Harris AW, Williams LM.
    Psychiatry Res; 2005 Aug 30; 139(3):229-38. PubMed ID: 16055311
    [Abstract] [Full Text] [Related]

  • 12. Neuropsychological function-brain structure relationships and stage of illness: an investigation into chronic and first-episode schizophrenia.
    Premkumar P, Kumari V, Corr PJ, Fannon D, Sharma T.
    Psychiatry Res; 2008 Apr 15; 162(3):195-204. PubMed ID: 18226505
    [Abstract] [Full Text] [Related]

  • 13. Brain structural changes associated with chronicity and antipsychotic treatment in schizophrenia.
    Tomelleri L, Jogia J, Perlini C, Bellani M, Ferro A, Rambaldelli G, Tansella M, Frangou S, Brambilla P, Neuroimaging Network of the ECNP networks initiative.
    Eur Neuropsychopharmacol; 2009 Dec 15; 19(12):835-40. PubMed ID: 19717283
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC, Cerasa A, Liguori M, Passamonti L, Condino F, Vercillo L, Valentino P, Clodomiro A, Quattrone A, Fera F.
    Brain Res; 2007 Sep 05; 1167():71-9. PubMed ID: 17689504
    [Abstract] [Full Text] [Related]

  • 16. Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity.
    Schiffer B, Müller BW, Scherbaum N, Forsting M, Wiltfang J, Leygraf N, Gizewski ER.
    Brain; 2010 Oct 05; 133(10):3093-103. PubMed ID: 20647266
    [Abstract] [Full Text] [Related]

  • 17. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems.
    van den Heuvel OA, Remijnse PL, Mataix-Cols D, Vrenken H, Groenewegen HJ, Uylings HB, van Balkom AJ, Veltman DJ.
    Brain; 2009 Apr 05; 132(Pt 4):853-68. PubMed ID: 18952675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia.
    Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May 05; 29(4):587-91. PubMed ID: 15866362
    [Abstract] [Full Text] [Related]

  • 20. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects.
    Bergé D, Carmona S, Rovira M, Bulbena A, Salgado P, Vilarroya O.
    Acta Psychiatr Scand; 2011 Jun 05; 123(6):431-9. PubMed ID: 21054282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.